BHVN Reports $12M Q1 Revenue, $0.05 EPS, Updates Pipeline: Opakalim 2H26 Data, Taldefgrobep 2H26, BHV-1400/BHV-1300 Pivotal 2H26, BHV-1530 Escalation, 5 AAN Abstracts
Biohaven Ltd. · PHARMACEUTICAL PREPARATIONS · Now $11.43
-11% in 7d after detection
Post-detection moves
1h
—
1d
-4.2%
3d
-3.9%
7d
-11%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS